Cutting edge: The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1

Citation
Yy. Le et al., Cutting edge: The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1, J IMMUNOL, 166(3), 2001, pp. 1448-1451
Citations number
24
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
166
Issue
3
Year of publication
2001
Pages
1448 - 1451
Database
ISI
SICI code
0022-1767(20010201)166:3<1448:CETNPP>2.0.ZU;2-M
Abstract
Prion diseases are transmissible and fatal neurodegenerative disorders whic h involve infiltration and activation of mononuclear phagocytes at the brai n lesions. A 20-aa acid fragment of the human cellular prion protein, PrP10 6-126, was reported to mimic the biological activity of the pathologic isof orm of prion and activates mononuclear phagocytes, The cell surface recepto r(s) mediating the activity of PrP106-126 is unknown. In this study, we sho w that PrP106-126 is chemotactic for human monocytes through the use of a G protein-coupled receptor formyl peptide receptor-like 1 (FPRL1), which has been reported to interact with a diverse array of exogenous or endogenous ligands. Upon stimulation by PrP106-126, FPRL1 underwent a rapid internaliz ation and, furthermore, PrP106-126 enhanced monocyte production of proinfla mmatory cytokines, which was inhibited by pertussis toxin, Thus, FPRL1 may act as a "pattern recognition" receptor that interacts with multiple pathol ogic agents and may be involved in the proinflammatory process of prion dis eases.